After a number of price hesitations, Nanosphere, Inc. (NASDAQ:NSPH) got the climb. Yesterday, the stock soared 20.47%, on a 
traded volume exceeding 1 million shares.
One of the most reasonable explanations on the gain seems to be the latest news on Nanosphere. Yesterday, a few different websites reported that FDA has approved the company’s bacterial infection test.
The positive announcement made NSPH stock price jump up at once and now it is interesting how far the up move may go.
In order to additionally secure its chart position, NSPH got promoted yesterday. The promoters put the stock on their watchlists for today and the result should be seen shortly.[BANNER]
Meanwhile, the financial condition of Nanosphere does not look much promising. On the contrary, its last 10-Q states that the company has incurred net losses attributable to common stock of $306.7 million since inception. Thus, NSPH may need additional financing before year-end 2012 to execute on its current or future business strategies.
However, the amount and the timing of the additional capital Nanosphere needs to raise depends on many factors, which are beyond the company’s control. At the same time, if NSPH raises additional funds through the issuance of equity or convertible debt securities, the percentage ownership of its stockholders could be significantly diluted.
